Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC | The Arizona Clinical Oncology Society
Neil M. Iyengar, MD; Kit Lu, MD
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease | Michigan Regional Program
Jacob Sands, MD; Shiven B. Patel, MD, MBA, FACP
Advances in Rethinking Risk After Resection in Early-Stage NSCLC
Millie Das, MD; David R. Gandara, MD; Johannes R. Kratz, MD
Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma | South Carolina Oncology Society
Geoffrey Ku, MD; Shiven B. Patel, MD, MBA, FACP
Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma | Texas Society of Clinical Oncology
Syma Iqbal, MD; Shiven B. Patel, MD, MBA, FACP
Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma | Kentucky Society of Clinical Oncology
Sunnie S. Kim, MD; Jack W. Erter III, MD, MMHC
Rethinking Immune Drivers of MS: The CD40/CD40L Connection
March 11, 2027
Tumor Board: Integrating Immunotherapy With Definitive and Perioperative Radiation Strategies in Stage I-III NSCLC
Joe Y. Chang, MD, PhD, FASTRO, FACR; Nitin Ohri, MD, MS; Biagio Ricciuti, MD, PhD
Cases and Conversations—Evolving Radiation Strategies in HER2-Positive Breast Cancer: Early-Stage Through Metastatic Disease
Reshma Jagsi, MD, DPhil; Lior Z. Braunstein, MD; Neil M. Iyengar, MD
Show Me the Data®: Redefining Extensive-Stage SCLC—Emerging Therapies, CNS Considerations, and the Radiation Oncologist’s Evolving Role
Kristin Higgins, MD; Alissa J. Cooper, MD; Percy Lee, MD, MBA, FASTRO
Community Oncology Connections™: Bridging Academic and Community Connections to Advance Precision and Targeted Care in NF1 Plexiform Neurofibromas | Colorado Oncology Society
Daniela A. Bota, MD, PhD; Shiven Patel, MD, MBA
Jersey City 2026: Integrating Glutamatergic Agents to Advance Care for Patients with MDD
Anita H. Clayton, MD; Joseph F. Goldberg, MD
Jersey City 2026: Integrating Motivational Interviewing Techniques to Overcome Barriers to the Use of Long-Acting Injectable Agents in Patients With Schizophrenia
Christoph U. Correll, MD; Jose M. Rubio, MD, PhD
Jersey City 2026: Improving Identification and Management of Patients with Tardive Dyskinesia
Jose M. Rubio, MD, PhD; Erin Crown, MHS, PA-C, Psych-CAQ; John J. Miller, MD
Jersey City 2026: Optimizing Treatment for Difficult-to-Treat Depression: The Role of Vagal Nerve Stimulation Therapy
Gus Alva, MD, DLFAPA; Lisa Harding, MD; Joseph F. Goldberg, MD
Community Oncology Connections™: Bridging Academic and Community Connections to Advance Precision and Targeted Care in NF1 Plexiform Neurofibromas | Tennessee Oncology Practice Society
Amy E. Armstrong, MD; Tarun Wasil, MBBS
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC
Neil M. Iyengar, MD; Sara M. Tolaney, MD, MPH
Beyond the Basics in CIDP — Confronting Misdiagnosis and Rethinking Treatment Strategy
Thomas H. Brannagan III, MD
Medical Crossfire®: Where CAR T and Bispecific Antibodies Fit in Lymphoid Malignancies Today… and Tomorrow
Krina K. Patel, MD, MSc; Juan Pablo Alderuccio, MD; Christopher R. Flowers, MD, MS, FASCO; Matthew L...
Navigating the Evolving Landscape of Acute Lymphoblastic Leukemia
Hagop M. Kantarjian, MD; Elias Jabbour, MD; Aaron C. Logan, MD, PhD, MPhil
Reel Time Patient Counseling™: Improving Quality of Life for Patients With Acute Pain
Javier Morales, MD; Charles E. Argoff, MD
What, When, In What Order? Navigating the Ever-Expanding Treatment Landscape for Generalized Myasthenia Gravis
Ali A. Habib, MD
Multidisciplinary Approaches to Diagnosis and Management of Muscular Dystrophy
Katherine Mathews, MD
What Is Coming Down the Pipeline for Generalized Myasthenia Gravis (gMG)?
James F. Howard Jr, MD, FAAN
Myasthenia Mimics — How to Differentiate Between Similar Neuromuscular Disorders
Ali A. Habib, MD
Community Practice Connections™: Bridging Academic and Community Connections to Advance Precision and Targeted Care in NF1 Plexiform Neurofibromas
Amy E. Armstrong, MD; Daniela A. Bota, MD, PhD
Medical Crossfire®: ADCs and Bispecifics in Lung Cancer—Hype, Hope, or a New Standard of Care?
Sandip Patel, MD, FASCO; Enriqueta Felip, MD, PhD; Marina Chiara Garassino, MD; Eric K. Singhi, MD
𝘒𝘙𝘈𝘚 in Focus: Navigating the Mutation-Driven Oncology Landscape – Nursing
David S. Hong MD; Kathryn C. Arbour, MD; Shubham Pant, MD, MBBS; Alison Schram, MD
Differentiating Neuroinflammatory Disorders
Michael Levy, MD, PhD; Eoin Flanagan, MB, BCh
From Lived Experience to Precision Care: Patient, Provider, and Caregiver Insights in Cutaneous Lupus Erythematosus
Alfred Kim, MD; Victoria Werth, MD
Community Oncology Connections™: Bridging Academic and Community Connections to Advance Precision and Targeted Care in NF1 Plexiform Neurofibromas | North Carolina Oncology Association
Daniela A. Bota, MD, PhD; Maya Hrachova, DO
Clinical Crossroads™: The Importance of Timely Identification and Management of Risk Factors for Seizure Clusters
Joseph I. Sirven, MD; Danielle Becker, MD, MS
Patient, Provider, Caregiver Connection™: Individualized Care in Pediatric Atopic Dermatitis
Elizabeth (Lisa) A. Swanson, MD; Linda Stein Gold, MD
Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management
Edward B. Garon, MD, MS; Emely Alfaro, DNP, RN, CNS, OCN; Marianne Davies, NP, DNP, MSN, APRN, BSN; ...
Medical Crossfire®: Personalizing the Management of Multiple Sclerosis: Optimizing the Selection of Disease Modifying Therapies
Benjamin Greenberg, MD; Jiwon Oh, MD; Amy Perrin Ross, APN, MSN, CNRN, MSCN
𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment
Jonathan Goldman, MD; Sanja Dacic, MD, PhD; Deborah Doroshow, MD, PhD; Anne S. Tsao, MD, MBA
BURST CME™ Activity 4: Case-Based Discussions in HR+/HER2– MBC: Incorporating the Latest Data Into Practice
Erica L. Mayer, MD, MPH; Jason Aboudi Mouabbi, MD; Erika P. Hamilton, MD
PER Postgame: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice
Judy E. Kim, MD, FARVO, FASRS
Project ECHO®: Managing Toxicities and Expectations With Novel Treatment Strategies in mTNBC: A Team-Based Approach
Tiffany A. Traina, MD, FASCO; Nour Abuhadra, MD; Ya Haddy Sallah, MD, MPH; Odessa M. Williams, AGPCN...
Cases & Conversations: Real-World Insights on the Diagnosis and Management of Cold Agglutinin Disease
Catherine M. Broome, MD; Wilma Barcellini, MD, PhD; Sigbjørn Berentsen, MD, PhD; Marc Michel, MD, MS...
Medical Crossfire®: BPDCN in 2026—Expert Perspectives on Diagnosis, Frontline Therapy, and the Evolving CD123-Directed Pipeline
Andrew A. Lane, MD, PhD; Marlise Luskin, MD, MSCE; Kendra Sweet, MD
OncoBytes Adaptive Learning Pathways™: Decoding Precision Diagnostics and Targeted Therapies in Glioma
Vinay K. Puduvalli, MD; Ruham Nasany, MD; Angela Waanders, MD, MPH, MS
















































